Geode Capital Management, LLC Neurocrine Biosciences Inc Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,969,754 shares of NBIX stock, worth $263 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,969,754
Previous 1,875,062
5.05%
Holding current value
$263 Million
Previous $256 Million
14.88%
% of portfolio
0.02%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding NBIX
# of Institutions
652Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$739 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$649 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$357 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...